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ABSTRACT: New methods for delivering proteins into the cytosol of
mammalian cells are being reported at a rapid pace. Differentiating between
these methods in a quantitative manner is difficult, however, as most assays
for evaluating cytosolic protein delivery are qualitative and indirect and thus
often misleading. Here we make use of fluorescence correlation spectroscopy
(FCS) to determine with precision and accuracy the relative efficiencies with
which seven different previously reported “cell-penetrating peptides” (CPPs)
transport a model protein cargothe self-labeling enzyme SNAP-tag
beyond endosomal membranes and into the cytosol. Using FCS, we
discovered that the miniature protein ZF5.3 is an exceptional vehicle for
delivering SNAP-tag to the cytosol. When delivered by ZF5.3, SNAP-tag can
achieve a cytosolic concentration as high as 250 nM, generally at least 2-fold and as much as 6-fold higher than any other CPP
evaluated. Additionally, we show that ZF5.3 can be fused to a second enzyme cargothe engineered peroxidase APEX2and
reliably delivers the active enzyme to the cell interior. As FCS allows one to realistically assess the relative merits of protein
transduction domains, we anticipate that it will greatly accelerate the identification, evaluation, and optimization of strategies to
deliver large, intact proteins to intracellular locales.
■ INTRODUCTION
The approval of recombinant human insulin in 1982 heralded
the emergence of protein-based therapeutics as a major
pharmaceutical class.1,2 As of late 2017, 239 therapeutic
proteins and peptides (also known as biologics) have been
approved for clinical use in the U.S.1 This class encompasses
hormones, coagulation factors, and monoclonal antibodies that
act in plasma or on the cell surface2 to combat cancer,3,4
diabetes,5 autoimmune disorders,6−9 hematological disor-
ders,10 lysosomal storage disorders,11,12 and other human
diseases.2 Despite this progress, the potential of protein-based
therapeutics remains grossly underdevelopednot a single
FDA-approved biologic acts on a molecular target within the
cytosol or nucleus. The extreme challenge of delivering intact
proteins to the cell interior hampers the use of these materials
as potential therapeutics and research tools.
Hundreds of putative cell-penetrating peptides (CPPs) have
been studied in the hope of overcoming the challenges
associated with intracellular protein delivery.13 The most
common CPPs contain multiple arginine and/or lysine
residues, bear a high net positive charge, and exhibit some
structural disorder.14 These unstructured CPPs (uCPPs), a
class that includes Tat48−60,
15 penetratin,16 oligo-arginine
sequences,17,18 and others,19 have been reported to deliver
assorted protein, nucleic acid, small molecule, and nanoparticle
cargoes with varying success.20 Numerous studies have
confirmed that at low micromolar concentrations, most
(although not all)21 uCPP−protein conjugates enter cells via
energy-dependent endocytic mechanisms.22−25 However,
trafficking to the cytosol requires at least two steps: uptake
from the cell surface into the endocytic pathway and release
from endosomes into the cytosol. The problem is that although
uptake of uCPP−cargo conjugates into endosomes can be
efficient, their subsequent release into the cytosol is not.26 As a
result, most uCPP−cargo conjugates are destined for
lysosomes and ultimately degraded.27 Despite this inherent
limitation, several uCPP-derived therapeutics have yielded
promising results for a variety of disease models, suggesting
that even very low delivery levels can establish a therapeutic
effect in some cases.28 Our group and many others have
focused on the development of improved strategies to promote
endosomal release and thereby facilitate the delivery of
peptides and proteins into the cytosol.29−45
A critical challenge limiting the development of truly cell-
permeant peptides and proteins is the absence of convenient
and direct assays to determine the concentration of intact
cargo that reaches the cytosol or nucleus. Most assays used for
this purpose are qualitative, indirect, or amplify a small signal
in a nonlinear manner. The most common qualitative assay
evaluates cells treated with a fluorescently labeled CPP−cargo
conjugate using both flow cytometry and confocal microscopy.
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As pointed out previously,38,46,47 although flow cytometry and
confocal microscopy provide qualitative information about
total cellular uptake, neither distinguishes fluorescent material
in the cytosol or nucleus from that adhered to the plasma
membrane or trapped within endosomal (or other) compart-
ments. Microscopy-based experiments can be especially
misleading because even mild fixation leads to the intracellular
redistribution of CPPs from endosomes to the cytosol.
Additionally, membrane-associated peptides, if not carefully
removed using trypsin, can contribute to the fluorescence
signal intensity observed by microscopy or flow cytometry.23
As an alternative to flow cytometry and confocal
microscopy, several groups have reported functional or
fluorescence-based assays to evaluate cytosolic localization.
Functional assays include those based on the recombination
and expression of a reporter gene mediated by Cre
recombinase36,48−50 or Cas9;49 although these assays are easy
to implement, they can also be misleading because the
relationship between delivery and assay read-out is amplified,
not linear. Other qualitative functional assays are based on the
cytosolic delivery of small molecule-tagged peptides that illicit
a measurable phenotypic change, such as luciferin-tagged
peptides reacting with cytosolic luciferase to produce a
luminescent read-out,51 or dexamethasone-tagged peptides
for inducing the glucocorticoid-mediated translocation of
cytosolic eGFP into the nucleus. These assays are also easy
to implement, but often assume that the luciferase−luciferin
(or dexamethasone−GR) interaction is unaffected by the
cargo. Alternatively, protein fusions that can only be
enzymatically modified in cell cytosol, such as ubiquitin37,52
or avi-tagged protein variants53,54 (substrates of cytosolic
deubiquitinases and biotin ligase, respectively) have been used
as model cargos for assessing cytosolic delivery. However, this
approach requires the addition of a small protein or large
peptide tag to the cargo under study, which may not always be
tolerated in a protein sequence. Moreover, both methods
require analysis by Western blot, which is not reliably
quantitative.55 Fluorescence-based assays for evaluating deliv-
ery into the cytosol include FRET-based systems,56 fluorogenic
probes that turn on in the presence of cell cytosol57 or
cytosolic enzymes,58,59 and split GFP reporter assays.30,60,61
However, in all cases these methods yield an amplified or
indirect read-out that is only appropriate for rendering
qualitative or semiquantitative comparisons of cytosolic
delivery. Recently, Peraro et al. developed a high-throughput
cell penetration assay based on the Halo-tag system.62 While
this assay quantitatively compares the cytosolic levels achieved
by chloroalkane-tagged peptides, it is unable to distinguish
degraded material from that which reaches the cytosol intact.
Moreover, it has not yet been adapted for assessing the delivery
of large proteins into cell cytosol. Taken together, the lack of a
reliable method for directly measuring the cytosolic concen-
trations achieved by cell-permeant peptides and proteins has
hindered progress in the field for years.
We have previously reported that small, folded miniature
proteins derived from avian pancreatic polypeptide (aPP) or an
isolated zinc-finger (ZF) domain can be rationally engineered
for high cell uptake,38,46,63 and that their trafficking to the
cytosol can be determined with accuracy and precision using
fluorescence correlation spectroscopy (FCS).47 FCS is a
powerful single-molecule technique capable of measuring the
concentration of a fluorescent molecule in the cytosol or
nucleus of a live cell.64,65 During an FCS experiment, one
records the time-dependent fluctuations in fluorescence
intensity of single fluorescent molecules passing through a
small (sub-femtoliter) focal volume. These time-dependent
fluctuations can be autocorrelated to extract meaningful
physical parameters such as the diffusion coefficient and local
concentration of the fluorescent molecule.66 Using FCS, we
found that miniature proteins containing a discrete array of five
α-helical arginine side chains reached the cytosol in exceptional
yields with transport efficiencies ranging from 50−75%.47
Notably, the transport efficiency of the most efficient cell-
permeant miniature protein (CPMP) ZF5.3 exceeded by
nearly 10-fold the values measured for previously reported
uCPPs.
Intrigued by the efficiencies with which the isolated CPMPs
aPP5.3 and ZF5.3 traffic into the cytosol, we sought to evaluate
their ability to deliver large proteins into cells in a direct, head-
to-head comparison with several other peptide-based delivery
vehicles. Specifically, we made use of a commercial, easy-to-use
FCS system to directly quantify the relative efficiencies with
which two traditional uCPPs, three CPMPs, and two recently
reported cell-penetrating cyclic peptides (cCPPs) deliver a full-
length protein cargothe self-labeling enzyme SNAP-tag67
into the cytosol of mammalian cells. Using FCS and this set of
fluorescent SNAP-tag conjugates (Figure 1A), we discovered
that the CPMP ZF5.3 remains a superior cytosolic delivery
vehicle even when appended to an enzyme cargo of significant
mass. When delivered by ZF5.3, SNAP-tag can achieve a
cytosolic concentration as high as 250 nM, generally at least 2-
fold and as much as 6-fold higher than any other CPP
Figure 1. (A) Workflow to determine the overall uptake and cytosolic
concentration of a self-labeled CPMP, cCPP, or uCPP SNAP-tag
conjugate using flow cytometry and FCS. The sequence of each
vehicle studied in this report is listed above. For ZF5.3 and aPP5.3,
the residues comprising the 5.3 motif are shown in red. For CPP9 and
CPP12, lowercase letters represent D-amino acids, Φ represents L-
naphthylalanine, and PEG2 represents a 2-unit ethylene glycol spacer.
(B) Mechanism of SNAP-tag self-labeling with a fluorophore-
containing benzylguanine derivative.
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evaluated. As we have reported previously, the extent of
cytosolic localization does not always mirror the extent of
overall uptake ascertained by flow cytometry, demonstrating
the value of a technique that measures concentration directly,
such as FCS. To demonstrate that ZF5.3-mediated delivery is
not restricted to a single protein, we conjugated it to the
enzyme APEX2,68 assessed cytosolic trafficking using FCS, and
evaluated peroxidase activity in cellulo. Taken together, we have
shown that FCS can realistically assess the relative merits of
protein transduction domains for shuttling protein cargo
beyond membrane barriers, and that the CPMP ZF5.3 holds
particular promise as a robust tool for delivering active
enzymes into cells.
■ RESULTS AND DISCUSSION
The Self-Labeling Protein SNAP-tag as a Common,
Easily Labeled Cargo. In order to provide a direct and
quantitative comparison of protein delivery by previously
reported uCPPs, CPMPs, and cCPPs, we sought a well-
characterized protein that could be labeled in a homogeneous
and stoichiometric manner with a bright photostable dye. We
envisioned that this goal would be achieved most easily using a
well-studied, self-labeling protein tag such as SNAP,67 CLIP,69
or Halo.70 While we considered using FCS-compatible red
fluorescent proteins as model cargo, we were concerned by
their complex photophysical properties and known tendency to
form multimers in vitro and in live cells.71,72 By contrast,
SNAP-tag, an engineered human O6-alkylguanine-DNA-alkyl-
transferase variant, reacts efficiently, in vitro and in vivo, with
fluorophore-substituted O6-benzylguanine (BG) or chloropyr-
imidine (CP) substrates to form covalent SNAP-tag-
fluorophore conjugates (Figure 1B). Virtually all SNAP-tag-
protein fusions retain O6-alkylguanine-DNA-alkyltransferase
activity and the ability to self-label.73 Moreover, the SNAP-tag
enzyme is monomeric, highly thermostable (TM = ∼70 °C),
and resists degradation by intracellular proteases (t1/2 = ∼42 h
in HEK293T cells).74 These features render SNAP-tag an
attractive model enzyme for the comparative evaluation of
uCPP, CPMP, and cCPP-mediated cytosolic delivery.
Previously, we reported FCS experiments that measured the
cytosolic concentrations attained when the isolated CPMPs
aPP5.3 and ZF5.3 were incubated with cells in culture, but we
did not evaluate their ability to deliver appended protein cargo.
In this work, we chose to compare cargo delivery by aPP5.3
and ZF5.3 to three canonical uCPPsR8, Tat, and penetratin
(Pen, also known as antennapedia)and to the zinc finger
known as ZiF.13,20,37 The materials needed for this comparison
were easy to prepare, as each CPMP or uCPP is genetically
encodable. Indeed, the C-terminally His-tagged SNAP-tag
fusion proteins ZF5.3-SNAP, aPP5.3-SNAP, ZiF-SNAP, R8-
SNAP, and Pen-SNAP, as well as the control protein SNAP
lacking an appended CPP, expressed readily in Escherichia coli
and were purified to homogeneity by immobilized metal
affinity chromatography (IMAC). Notably, the isolated yields
of the CPMP-SNAP conjugates ZF5.3-SNAP, aPP5.3-SNAP,
and ZiF-SNAP were much higher (20−30 mg/L) than those of
the uCPP-SNAP conjugates R8-SNAP and Pen-SNAP (5 mg/
L). Following purification, the identity of each protein was
confirmed by mass spectrometry (MS), and the purity was
assessed by SDS-PAGE (Figure S1). We were unfortunately
unable to isolate any full-length Tat-SNAP even after
significant experimental optimization, and no additional
experiments were performed with this conjugate.
We also sought to compare aPP5.3 and ZF5.3 to a set of
cyclic peptides that have been reported by others to enter the
cell cytosol, most notably CPP9 and CPP12, sequence variants
of the cyclic peptide known as cFΦR4.35,76 In previous work,
cytosolic localization of the isolated CPP9 and CPP12 peptides
(no cargo) was estimated from flow cytometry experiments
using variants linked covalently to a dye that is ∼10-fold more
fluorescent at neutral pH than at pH ≤ 6.0; like other assays
based on fluorescence intensity, this method provides only an
estimate of cytosolic concentration.57,76 Using this assay, the
cytosolic trafficking of CPP9 and CPP12 was estimated to
approach that of aPP5.3, which encouraged us to evaluate their
relative merits using the more quantitative method of FCS and
in a more relevant context in which both are linked to a model
cargo protein.76 However, unlike the uCPPs and CPMPs
described above, CPP9 and CPP12 contain nonproteinogenic
amino acids and cannot be easily genetically encoded to
produce the requisite fusion protein. In an earlier study,
cFΦR4 was conjugated to the N-terminus of a protein using
the peptide carrier protein Sfp phosphopantetheinyl transferase
(Sfp).35 While this method allows for site-specific labeling, it
requires modification of the protein of interest with an 11-
residue Sfp recognition sequence.77 Moreover, Sfp labeling
requires CoA-derivatized peptides, which require multiple
steps after solid phase synthesis to prepare and are costly to
scale.35 Rabideau et al. have shown that the enzyme sortase can
ligate unnatural synthetic peptides, including cyclic peptides,
onto the C-terminus of full-length proteins.78 Inspired by this
report, we designed a straightforward strategy to ligate CPP9
and CPP12 to the N-terminus of SNAP-tag through a covalent
linkage (Figure 2). The identity and purity of each cCPP-
SNAP-tag conjugate were ultimately assessed by MS and SDS-
PAGE, respectively (Figure S1). To prepare for FCS, each
SNAP-tag conjugate was incubated with BG-Lissamine rhod-
amine B (Rho) for 2 h at 37 °C. Rho was selected as the dye of
choice because it is compatibile with FCS and cannot
penetrate cells on its own.47 All of the SNAP-tag conjugates
Figure 2. Sortase-based ligation strategy for generating CPP9- and
CPP12-SNAP. To prepare SNAP-His6 bearing an N-terminal
triglycine sequence for sortase labeling, we expressed and purified a
variant containing an N-terminal Factor Xa recognition site (MIEGR)
followed by a triglycine motif to yield MIEGR-G3-SNAP-His6.
MIEGR-G3-SNAP-His6 was cleaved with Factor Xa to yield G3-
SNAP-His6. G3-SNAP-His6 was then incubated with excess CPP9-
LPETG3 or CPP12-LPETG3 in the presence of the engineered sortase
variant SrtA7M75 to generate the desired conjugate in good (>50%)
yields. To isolate CPP9- and CPP12-SNAP-His6 from the reaction
mixture, we employed a two-step chromatographic strategy to isolate
the desired conjugates (see Methods for additional details).
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that we examined retained robust self-labeling activity in vitro;
in each case, we observed quantitative and homogeneous
labeling. SDS-PAGE and MS analyses confirmed the identity,
homogeneity, and purity of each Rho-labeled SNAP-tag
conjugate used in cellular assays (Figure S2).
Comparing Overall Uptake: Confocal Microscopy.
With a set of fluorescently tagged SNAP-tag conjugates in
hand, we first sought to evaluate their overall uptake into cells
using confocal microscopy (Figure 3). Saos-2 cells were
incubated for 30 min with 1 μM of each Rho-labeled SNAP-tag
conjugate and then with 300 nM Hoechst 33342 to visualize
the cell nucleus. The cells were washed, treated with trypsin to
remove surface-bound protein and lift the cells, replated onto
fibronectin-coated glass microscopy slides, and imaged. These
images (Figure 3A) revealed low levels of intracellular
fluorescence when cells were treated with SNAP-Rho and
CPP9-SNAP-Rho, suggesting that under these conditions, the
presence of CPP9 does not significantly enhance the uptake of
an appended SNAP-tag cargo by Saos-2 cells. Cells treated
with CPP12-SNAP-Rho, aPP5.3-SNAP-Rho, R8-SNAP-Rho,
ZiF-SNAP-Rho, and Pen-SNAP-Rho exhibited bright punctate
fluorescence, suggesting significant levels of endocytic uptake,
but no observable cytosolic fluorescence. Saos-2 cells treated
with ZF5.3-SNAP-Rho displayed bright punctate fluorescence
as well as diffuse cytosolic fluorescence, suggesting significant
levels of both endocytic uptake and cytosolic release. Overall,
these qualitative confocal microscopy results suggest that
ZF5.3-SNAP-Rho reaches the cytosol of Saos-2 cells, whereas
the other conjugates do so to a lesser extent or not at all.
Quantifying Overall Uptake: Flow Cytometry. The
differences in the overall uptake of each SNAP-tag conjugate
suggested by confocal microscopy were studied further using
flow cytometry. Treatment of Saos-2 cells with 1 μM of each
Rho-labeled SNAP-tag conjugate as described above led to
evenly distributed populations of fluorescent cells (Figure 3B);
the median fluorescence intensity of this distribution over 3−5
independent replicates is also shown (Figure 3C). Overall, the
CPPs and CPMPs studied fall into four categories: cells treated
with CPP9-SNAP-Rho were not measurably more fluorescent
than cells treated with SNAP-Rho, as expected from the
microscopy experiments described above. Cells treated with
CPP12-SNAP-Rho and aPP5.3-SNAP-Rho showed compara-
ble levels of fluorescence throughout the cell interior, reaching
values approximately 2-fold higher than that observed when
cells were treated with SNAP-Rho. Cells treated with R8-
SNAP-Rho and ZiF-SNAP-Rho exhibited higher levels of total
cellular fluorescence that were nearly 5-fold higher than that of
cells treated with SNAP-Rho. The highest levels of total
intracellular fluorescence were observed when cells were
treated with Pen-SNAP-Rho (an 11-fold increase relative to
cells treated with SNAP-Rho) and ZF5.3-SNAP-Rho (a 17-
fold increase relative to cells treated with SNAP-Rho). Overall,
we observed good agreement between data from confocal
microscopy and flow cytometry experiments performed using
Saos-2 cells.
To broaden these findings, we repeated the flow cytometry
experiments in two other common cell lines (HeLa and SK-
HEP-1) and obtained similar results, implying that the level to
which each SNAP-tag conjugate is taken up by endocytosis is
comparable within this set of cell lines (Figure S3). These
results are consistent with previous flow cytometry studies
demonstrating that the overall cellular uptake of ZF5.3 is
significantly higher than that of uCPPs and other CPMPs.46,47
Our results are also consistent with flow cytometry studies
demonstrating that the total levels of ZiF-mediated protein
delivery are similar to those achieved by uCPPs.37 In addition,
we found the overall uptake of Pen-SNAP-Rho to be
significantly higher than that of R8-SNAP-Rho, which
contradicts several uptake studies performed with molecules
lacking an appended cargo.25,79,80 Finally, in light of a
previously published report,76 we were surprised to find that
the overall uptake of cCPP-SNAP-tag conjugates (CPP9-
SNAP-Rho and CPP12-SNAP-His6-Rho) were significantly
lower than those measured for any other tested uCPP or
CPMP conjugate. As a whole, our results demonstrate that the
CPMP ZF5.3 promotes the efficient uptake of a large
appended protein cargo across multiple cell lines, while other
CPMPs, uCPPs, and cCPPs do so to a lesser extent.
Quantifying Cytosolic Localization: Fluorescence
Correlation Spectroscopy (FCS). After assessing cellular
uptake by confocal microscopy and flow cytometry, we used
FCS to determine the amount of labeled SNAP-tag protein
that reaches the cytosol of live cells. Saos-2 cells were prepared
for FCS experiments in the same manner as described for
confocal microscopy. After confocal images were acquired,
cells were scanned visually to identify locations for cytosolic
focal volume placement; nuclear regions were avoided, as were
regions with high punctate signal representative of endosomes.
The acquired correlation data were fit to a three-dimensional
(3D) diffusion model containing a parameter for anomalous
Figure 3. Total cell uptake of Rho-tagged SNAP-tag conjugates
assessed by confocal microscopy (A) and flow cytometry (B and C).
(A) Images of live Saos-2 cells treated with 1 μM of each SNAP-tag
conjugate for 30 min. Scale bar = 20 μm. (B) Histograms and (C) bar
plots illustrating the relative uptake of each Rho-tagged SNAP-tag
conjugate after 30 min incubation and trypsin treatment to remove
surface bound protein. MFI values represent the average median
fluorescence intensity of cells determined from 4−12 individual
replicates (10 000 cells each). Error bars represent the standard error
of the mean. MFI values corresponding to each SNAP-tag conjugate
were statistically compared to nontreated cells. ****p ≤ 0.0001, ***p
≤ 0.001, **p ≤ 0.01, *p ≤ 0.05; one-way ANOVA followed by post
hoc Dunnett’s test.
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subdiffusion using a custom MATLAB script as previously
described.47 The average diffusion times (τD) of the SNAP-tag
conjugates (Figure 4A) measured in the cytosol ranged
between 1.20 ± 0.66 and 2.67 ± 0.37 ms, approximately 6−
14-fold higher than values acquired in vitro (Figure S4), in
good agreement with the observed increase in cytoplasmic
diffusion times observed for intact peptides/proteins in living
cells.47,81 Notably, the intracellular diffusion time of each
SNAP-tag conjugate is at least 5-fold longer than the average
intracellular diffusion time measured for the 3.4 kDa Rho-
tagged stable peptide ZF5.3R (0.21 ± 0.025 ms).47 Since
diffusion time is proportional to molecular mass, this difference
provides strong evidence that the detected fluorescent signals
represent dye-protein conjugates and not released dye or small
protein fragments. To confirm that SNAP-tag remains intact
once delivered to the cytosol, cytosolic fractions obtained from
nontreated cells and from cells treated with ZF5.3-SNAP-Rho
were loaded onto an SDS-PAGE gel and analyzed by in-gel
fluorescence scanning followed by Western blotting with an
anti-SNAP-tag antibody. The cytosolic fraction obtained from
cells treated with ZF5.3-SNAP-Rho contained a single
fluorescent band that was positively identified as SNAP-tag
by Western blot analysis (Figure S5).
Imperfect Correlation between Overall Uptake and
Cytosolic Localization of SNAP-tag Conjugates. When
examined by FCS, the SNAP-tag conjugates studied fall into
two categories with respect to whether they reach the cell
cytosol after a 30 min incubation: those that accumulate to a
detectable level compared to SNAP-Rho and those that do not
(Figure 4B). SNAP-tag conjugates in the latter category
include CPP9-SNAP-Rho, CPP12-SNAP-Rho, aPP5.3-SNAP-
Rho, R8-SNAP-Rho, and ZiF-SNAP-Rho. Cells treated with 1
μM of these conjugates displayed a small (3−5-fold) but
statistically insignificant increase in cytosolic localization
relative to cells treated with SNAP-Rho, which accumulated
in the cytosol to reach a concentration of 1.8 ± 0.20 nM. Cells
treated with Pen-SNAP-Rho yielded a statistically significant
increase in cytosolic fluorescence that correlated with intra-
cellular concentrations between 5 and 65 nM, with an average
of 23 ± 2.9 nM. FCS measurements revealed that the cytosolic
concentration achieved by ZF5.3-SNAP-Rho was at least 2-fold
higher than that measured for Pen-SNAP-Rho, and more than
6-fold higher than the concentration measured for any other
SNAP-tag conjugate tested. For ZF5.3-SNAP-Rho, the
calculated cytosolic concentration after a 30 min incubation
ranged from 14 to 144 nM, with an average of 58 ± 6.1 nM.
Overall, our results demonstrate that both ZF5.3 and Pen are
effective vehicles for delivering SNAP-tag into the cytosol of
Saos-2 cells.
Effects of Concentration and Time. Next, we made use
of FCS to quantify the effects of concentration and incubation
time on the cytosolic localization of two SNAP-tag conjugates:
one that accesses the cytosol well (ZF5.3-SNAP-Rho) and one
that does not (CPP12-SNAP-Rho) (Figure 5A). First, Saos-2
cells were treated with increasing concentrations of ZF5.3-
SNAP-Rho or CPP12-SNAP-Rho (1−3 μM) for 30 min and
analyzed by flow cytometry and FCS as previously described
(Figure 5B). While we observed a dose-dependent increase in
the total cellular uptake by flow cytometry when Saos-2 cells
were treated with ZF5.3-SNAP-Rho (up to 4-fold), only a
modest increase was observed when cells were treated with
CPP12-SNAP-Rho (up to 2-fold). These trends are mirrored
by the FCS data: cells treated with increasing concentrations of
ZF5.3-SNAP-Rho showed a dose-dependent increase in
cytosolic concentration as determined by FCS. Treatment
concentrations of 1 and 2 μM ZF5.3-SNAP-Rho resulted in
average cytosolic concentrations of 58 ± 6.1 nM and 110 ± 13
nM, respectively, corresponding to an average delivery
efficiency of 6%. At the highest treatment concentration of 3
μM, we observed an average cytosolic concentration of 251 ±
34 nM, a delivery efficiency of 8%. In contrast, the cytosolic
Figure 4. Quantification of cytosolic delivery of Rho-tagged SNAP-
tag conjugates using FCS. Saos-2 cells were treated with 1 μM of each
SNAP-tag conjugate for 30 min and replated for FCS in the same
manner as described for confocal microscopy in Figure 2. (A)
Representative in cellulo FCS traces corresponding to each indicated
Rho-tagged SNAP-tag conjugate displaying the measured diffusion
time (τD) as well as the anomalous coefficient (a) associated with
each representative trace. (B) Scatter plot representation of
intracellular concentrations of Rho-tagged SNAP-tag conjugates
determined from respective autocorrelation fits. The average cytosolic
concentrations corresponding to each Rho-tagged SNAP-tag con-
jugate were statistically compared to the intracellular concentration of
Rho-tagged SNAP-tag lacking an appended vehicle. ****p ≤ 0.0001,
***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05 ; one-way ANOVA followed by
post hoc Dunnett’s test.
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concentration of CPP12-SNAP-Rho did not significantly
increase as a function of treatment concentration. At the
highest concentration tested, the delivery efficiency of CPP12-
SNAP-Rho was less than 1%.
In order to evaluate the effect of incubation time on
cytosolic delivery, we treated Saos-2 cells with 1 μM solutions
of ZF5.3-SNAP-Rho and CPP12-SNAP-Rho for 2 h (as
opposed to 30 min) prior to analysis by flow cytometry and
FCS (Figure 5C). Cells treated with ZF5.3-SNAP-Rho for 2 h
and evaluated using flow cytometry exhibited a 6.5-fold
increase in total intracellular fluorescence relative to cells
treated with the same concentration for 30 min; under these
conditions the cytosolic levels of ZF5.3-SNAP-Rho determined
using FCS increased by a factor of 2 (117 ± 19 nM). Cells
treated with CPP12-SNAP-Rho for 2 h and evaluated using
flow cytometry exhibited a 2-fold increase relative to cells
treated with CPP12-SNAP-Rho for 30 min. However, in
contrast to results obtained using ZF5.3-SNAP-Rho, we were
unable to detect a significant increase in the cytosolic
concentration of CPP12-SNAP-Rho after prolonged incuba-
tion times. Taken as a whole, these studies demonstrate that
FCS can be used to precisely examine the effects of treatment
concentration and incubation time on the delivery of protein
cargo into the cytosol, and that the extent of cytosolic
localization cannot be predicted by flow cytometry alone.
Ensuring Delivery of Active Enzymes. Next, we devised
an in cellulo assay to evaluate whether an unlabeled SNAP-tag
conjugate would retain self-labeling activity following intra-
cellular delivery (Figure 6A). We treated cells with 3 μM of
each unlabeled uCPP, CPMP, or cCPP SNAP-tag conjugate
for 30 min, washed the cells with DPBS (Dulbecco’s phosphate
buffered saline), and performed the labeling reaction in cellulo
by incubating the cells in media containing 1 μM SNAP-Cell©
505-Star for an additional 45 min. After the labeling period, the
cells were incubated with fresh media for 30 min to remove
unreacted SNAP-Cell© 505-Star, washed with DPBS, lifted
with trypsin, and imaged using confocal microscopy (Figure
6B). Cells treated with SNAP, CPP9-SNAP, and ZiF-SNAP
Figure 5. (A) Evaluation of the overall uptake and cytosolic delivery
of ZF5.3-SNAP-Rho and CPP12-SNAP-Rho with increasing treat-
ment concentration or time using flow cytometry and FCS. (B) Flow
cytometry bar plots (left) indicating total levels of cellular uptake and
scatter plot representation of cytosolic concentrations (right)
determined by FCS for varying treatment concentrations (1, 2, or 3
μM) of either CPP12-SNAP-Rho or ZF5.3-SNAP-Rho. (C) Flow
cytometry bar plots (left) indicating total levels of cellular uptake and
scatter plot representation of cytosolic concentrations (right)
determined by FCS with varying incubation times (30 or 120 min)
of either CPP12-SNAP-Rho or ZF5.3-SNAP-Rho (treatment
concentration 1 μM). MFI values represent the average median
fluorescence intensity of cells determined from 3−12 individual
replicates (10 000 cells each).
Figure 6. Evaluation of SNAP-tag activity in cellulo. (A) Scheme
depicting in cellulo labeling of SNAP-tag conjugate proteins with
SNAP-Cell© 505-Star. Saos-2 cells were incubated with 3 μM of each
unlabeled SNAP-tag conjugate for 30 min followed by treatment with
1 μM SNAP-Cell© 505-Star for 45 min. Intracellular fluorescence was
assessed using confocal microscopy and flow cytometry. (B) Confocal
microscopy images of live cells treated with each indicated SNAP-tag
conjugate and SNAP-Cell© 505-Star as described above. Scale bar =
20 μm. (C) Flow cytometry bar plots illustrating relative levels of total
intracellular fluorescence resulting from treatment with each SNAP-
tag conjugate followed by SNAP-Cell© 505-Star. MFI values
represent the average median fluorescence intensity of cells
determined from three individual replicates (10 000 cells each).
MFI values corresponding to each SNAP-tag conjugate were
compared to cells incubated with blank media (no added conjugate)
followed by SNAP-Cell© 505-Star. ****p ≤ 0.0001, ***p ≤ 0.001,
**p ≤ 0.01, *p ≤ 0.05; one-way ANOVA followed by post hoc
Dunnett’s test.
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displayed no significant intracellular fluorescence after treat-
ment with SNAP-Cell© 505-Star. Cells treated with CPP12-
SNAP displayed low levels of punctate fluorescence, whereas
cells treated with aPP5.3-SNAP and R8-SNAP displayed bright
punctate fluorescence. Cells treated with Pen-SNAP and
ZF5.3-SNAP exhibited exceptionally bright punctate fluores-
cence and low levels of diffuse cytosolic staining. We then
quantitatively compared the levels of intracellular fluorescence
(endosomes plus cytosol) after treatment with SNAP-Cell©
505-Star using flow cytometry (Figure 6C). Overall, there is
good agreement between the results of flow cytometry and
confocal microscopy. Cells treated with Pen-SNAP and ZF5.3-
SNAP and subsequently incubated with SNAP-Cell© 505-Star
were approximately 3.6- and 4.7-fold brighter, respectively,
than cells treated with SNAP-Cell© 505-Star alone. While we
intended to measure the precise concentration of each SNAP-
tag conjugate after labeling in cellulo using FCS, we were
unable to completely remove unreacted SNAP-Cell© 505-Star
(or three other fluorescent SNAP-tag substrates) from the
cytosol in untreated control samples and were concerned by
the heterogeneous nature of the acquired traces. Notwith-
standing this limitation, the confocal microscopy and flow
cytometry measurements confirm that delivered SNAP-tag
retains its activity in cells, despite its travels through the
endosomal pathway.82 Overall, the level of in cellulo SNAP-tag
activity exhibited by a given SNAP-conjugate correlates well
with cytosolic delivery (determined by FCS). The minor
discrepancies between these experiments could result, for
example, from subtle differences in SNAP-tag activity that
depend on CPP identity, or from a dye-dependent conforma-
tional change that alters CPP efficacy, or a combination of
these (or other) effects.
Delivery of Diverse Cargo. To demonstrate that FCS can
be used to monitor the cytosolic trafficking of an enzyme other
than SNAP-tag, we turned to the enzyme APEX2. APEX2 (28
kDa) is a monomeric, heme-binding, H2O2-dependent
peroxidase that is highly active in the mammalian cell
cytosol.68,83 We began by expressing variants of APEX2 and
a ZF5.3-APEX2 fusion protein that each carried a C-terminal
His tag and a sortase recognition motif to enable site-specific
tagging with a Rho-containing peptide (NH2-G3K-Rho, Figure
S6).84 While we attempted to express APEX2 variants
containing two of the more inefficient uCPPsR8 and
Tatboth could be expressed in only very low yield and
precipitated during dialysis; further optimization was not
pursued. APEX2, ZF5.3-APEX2, APEX2-LPETGG, and ZF5.3-
APEX2-LPETGG were overexpressed in E. coli and purified by
IMAC. After being labeled with sortase, APEX2-Rho and
ZF5.3-APEX2-Rho were purified to homogeneity (see
Methods for details). The identity and purity of APEX2,
ZF5.3-APEX2, APEX2-Rho, and ZF5.3-APEX2-Rho were
assessed by MS and SDS-PAGE, respectively (Figure S7).
The levels of heme-bound enzyme were determined
spectroscopically as described by Lam et al.68 To ensure that
the prepared enzymes were active, we compared the activity of
APEX2 and ZF5.3-APEX2 to APEX2-Rho and ZF5.3-APEX2-
Rho using a previously reported colorimetric guaiacol
oxidation assay and found that all four enzymes exhibit robust
peroxidase activity in vitro (Figure S8).68
Quantifying Total Cellular Uptake and Cytosolic
Localization of APEX2. With a set of Rho-tagged APEX2
enzymes in hand, we first evaluated their total uptake into cells
using confocal microscopy (Figure 7A) and flow cytometry
(Figure 7B). Saos-2 cells were treated with 1 μM of each
labeled enzyme for 30 min and prepared for confocal
microscopy and flow cytometry measurements in the same
manner as described for SNAP-tag. Cells treated with 1 μM
APEX2-Rho displayed minimal levels of punctate fluorescence,
whereas cells treated with 1 μM ZF5.3-APEX2-Rho displayed
much brighter, though predominantly punctate, intracellular
fluorescence. Further analysis by flow cytometry revealed that
cells treated with ZF5.3-APEX2-Rho were 2.4-fold brighter
than cells treated with APEX2-Rho, confirming that the
appended miniature protein enhances the total uptake of
APEX2 into cells. We then quantified the amount of APEX2-
Rho and ZF5.3-Rho that reaches the cytosol using FCS
(Figure 7C). The average diffusion times (τD) of ZF5.3-
APEX2-Rho and APEX2-Rho measured in the cytosol were
0.65 ± 0.057 and 0.95 ± 0.12 ms, respectively, approximately
4- and 6-fold longer than values acquired in vitro and at least 3-
fold longer than the intracellular diffusion time measured for
ZF5.3R (Figure S9). FCS measurements revealed that the
intracellular concentrations achieved by ZF5.3-APEX2-Rho
Figure 7. Assessment of ZF5.3-mediated delivery of APEX2-Rho. (A)
Confocal microscopy images of live Saos-2 cells treated with 1 μM of
each APEX2 conjugate for 30 min with the indicated Rho-tagged
SNAP-tag conjugate. Scale bar = 20 μm. (B) Flow cytometry bar plots
illustrating the relative uptake of each Rho-tagged APEX2 conjugate
after 30 min incubation and treatment with trypsin. MFI values
represent the average median fluorescence intensity of cells
determined from three individual replicates (10 000 cells each).
Error bars represent the standard error of the mean. MFI values
corresponding to each SNAP-tag conjugate were statistically
compared to nontreated cells. (C) Representative in cellulo FCS
traces (left) corresponding to each indicated Rho-tagged APEX2
conjugate displaying the diffusion time (τD) as well as the anomalous
coefficient (a) associated with each representative trace and scatter
plot representation (right) of intracellular concentrations of Rho-
tagged APEX2 conjugates determined from respective autocorrelation
fits. ****p ≤ 0.0001, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05; one-way
ANOVA followed by post hoc Dunnett’s test.
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ranged from 9 to 30 nM, with an average intracellular
concentration of 17 ± 1.0 nM, whereas the intracellular
concentration of APEX2-Rho ranged from 2 to 9 nM, with an
average of 4.7 ± 0.41 nM. The overall uptake and cytosolic
concentration of ZF5.3-APEX2-Rho were lower compared to
ZF5.3-SNAP-Rho, demonstrating the impact of cargo on the
potency of the appended CPMP. Certainly, more work is
needed to correlate cargo and CPP identity with the efficiency
of cytosolic access and characterize in more detail the precise
mechanism(s) by which endosomal escape occurs.
Evaluating the Activity of APEX2 Activity in Cells. To
evaluate whether APEX2 retained activity upon delivery to the
cytosol by ZF5.3, we made use of an assay developed by Ting
et al.68 that monitors the APEX2-dependent oxidation and
fluorescence turn-on of the cell-permeant dye Amplex
UltraRed (Figure 8A). Saos-2 cells were incubated with 500
nM of heme-bound APEX2 or ZF5.3-APEX2 for 30 min,
treated with trypsin to remove surface-bound enzyme,
transferred to microcentrifuge tubes, and resuspended in 100
μL of DPBS containing 10 μM of Amplex UltraRed and 1 mM
H2O2. After 1 min, intracellular fluorescence was analyzed
using flow cytometry (Figure 8B). Cells treated with ZF5.3-
APEX2 exhibited a 13-fold turn-on of fluorescence relative to
cells treated with Amplex UltraRed alone, whereas cells treated
with APEX2 exhibited only a 1.2-fold increase in fluorescence.
To visualize the APEX2-dependent turn-on of Amplex
UltraRed fluorescence in live cells, we performed a similar
experiment but visualized cells individually using confocal
microscopy (Figure 8C). Cells treated with ZF5.3-APEX2
displayed exceptionally bright punctate and cytosolic fluo-
rescence, whereas cells treated with APEX2 did not exhibit any
significant turn-on of Amplex UltraRed within the same
imaging time frame. Although these assays demonstrate that
ZF5.3-APEX2-His6 is active in cells, we acknowledge that the
pattern of Amplex UltraRed fluorescence may not accurately
depict the intracellular location of ZF5.3-APEX2-His6; Amplex
UltraRed that is oxidized in endosomal compartments by
entrapped ZF5.3-APEX2-His6 may also diffuse into the cytosol.
Regardless, these results demonstrate that the CPMP ZF5.3
can deliver active APEX2 into cells. Moreover, these results
emphasize the limited extent to which APEX2 activitywhich,
by nature, is amplifiedcorrelates with the relative levels of
APEX2 enzymes in the cell cytosol determined by FCS.
■ CONCLUSIONS
Cell-penetrating peptides,13 supercharged proteins,85−87 syn-
thetically surface-modified proteins,29,88,89 bacterial toxins,90
cationic lipids,49 induced transduction systems,39 and nano-
particles44,45 have all been evaluated as strategies for delivering
functional protein cargo into cells. Despite the increasing
number of reported methods for protein delivery, most assays
used to assess trafficking into the cytosol are qualitative and
indirect and can therefore be misleading. These limitations
make evaluating progress in the field of protein delivery
extremely challenging. In this work, we applied our previously
described FCS method47 to directly quantify the relative
efficiencies with which uCPPs, CPMPs, and synthetic cCPPs
transport a model self-labeled enzyme into cell cytosol. Unlike
any other reported strategy for assessing protein delivery, FCS
yields direct and precise measurements of cytosolic concen-
trations in living cells in real-time. Importantly, we found that
the extent of cytosolic trafficking of protein cargo cannot be
ascertained accurately using confocal microscopy, flow
cytometry, or enzymatic activity assaysthe compartmental
resolution and precision afforded by FCS were required to
distinguish conjugates that accumulate in the cytosol in
appreciable levels from those that do not.
Many of the differences between FCS and other, perhaps
less technical, assays stem from the fact that CPP-mediated
protein delivery into cell cytosol, in most cases, requires at least
two distinct steps: uptake by endocytosis and then endosomal
release. While many CPP−protein conjugates are readily
endocytosed, most fail to reach the cytosol due to endosomal
entrapment. In our study, we found that the cytosolic
concentrations measured by FCS correlated poorly with
overall uptake, suggesting that there are fundamental differ-
ences in the ability of each SNAP-tag conjugate to escape the
endocytic pathway. To more carefully assess endosomal escape
efficiency, we calculated an “endosomal escape ratio” (EER)
for each conjugate, which corresponds to the concentration of
a CPP−Snap-tag conjugate that reaches the cytosol divided by
the overall uptake as determined by flow cytometry, and
compared these values to SNAP-tag lacking an appended
vehicle (Figure S10). This analysis revealed that only two
molecules, the miniature protein ZF5.3 and the cyclic peptide
CPP9 promoted the endosomal release of SNAP-tag conjugate
significantly over background. Although the EER value
calculated for CPP9-SNAP-Rho is 1.3-fold higher than that
of ZF5.3-SNAP-Rho, the cytosolic concentration it achieves is
9.6-fold lower (Figure 4B). While we appreciate that this
finding is likely cargo-dependent, it does emphasize that the
combination of flow cytometry and FCS can be used to
evaluate the endosomal escape efficiency of any conjugate of
interest, provided that the molecule under study can be site-
specifically labeled with an appropriate fluorophore. We
anticipate that FCS techniques will dramatically accelerate
Figure 8. Evaluation of APEX2 activity in cellulo by flow cytometry
and confocal microscopy using Amplex UltraRed. (A) Scheme
depicting assay for assessing APEX2 activity in cellulo with Amplex
UltraRed. Saos-2 cells were incubated with 500 nM of each APEX2
conjugate for 30 min followed by treatment with 10 μM Amplex
UltraRed and 1 mM H2O2 for 1 min. Intracellular fluorescence was
assessed using confocal microscopy and flow cytometry. (B) Flow
cytometry bar plots representing the levels of intracellular Amplex
UltraRed fluorescence. MFI values represent the average median
fluorescence intensity of cells determined from three individual
replicates (10,000 cells each). Error bars represent the standard error
of the mean. (C) Confocal microscopy images of live cells treated
with 500 nM of each indicated APEX2 conjugate followed by 10 μM
Amplex UltraRed, and 1 mM H2O2 for 1 min. Scale bar = 20 μm.
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our ability to identify, evaluate, and optimize current strategies
for delivering large, intact proteins to intracellular locales.
■ METHODS
Safety Statement. No unexpected or unusually high safety
hazards were encountered.
Plasmid Cloning. Genes encoding ZF5.3-SNAP-His6,
aPP5.3-SNAP-His6, TAT-SNAP-His6, R8-SNAP-His6, ZiF-
SNAP-His6, G3-SNAP-His6, SrtA7M-StrepTagII, APEX2-His6,
and ZF5.3-APEX2-LPETGG-His6 were codon-optimized for
expression in E. coli and purchased as synthetic double-
stranded gBlocks (IDT) for plasmid construction using Gibson
assembly.91 Each synthetic gBlock was incorporated into a
linearized pET vector (originally pET32A) containing
complementary overhangs using commercial Gibson assembly
reagents and protocols. The sequences of the synthetic gBlocks
and primers used for generating additional expression plasmids
(SNAP-His6, MIEGR-G3-SNAP-His6, APEX2-His6, ZF5.3-
APEX2-His6, and APEX2-His6-LPETGG) are listed in the
Supporting Information.
Expression and Purification of SNAP-His6 Constructs.
Plasmids encoding each His-tagged SNAP-tag conjugate were
individually used to transform E. coli BL21(DE3) cells.
Individual colonies were selected on the basis of Ampicillin
(Amp) resistance and used to inoculate 5 mL of lysogeny
broth (LB) media supplemented with Amp (100 mg/L). The
primary cultures were used to inoculate 1 L of LB medium
supplemented with Amp, which was then allowed to grow at
37 °C with shaking at 200 rpm. When the OD600 reached 0.6−
0.8, the culture was cooled to 18 °C. Protein expression was
induced by the addition of IPTG to a final concentration of 1
mM. After 16 h, the cells were harvested by centrifugation and
lysed by sonication in 20 mM Tris pH 8.0, 150 mM NaCl, and
10% glycerol, supplemented with one cOmplete, Mini EDTA-
free protease inhibitor cocktail tablet. The cleared lysate was
obtained by centrifugation at 15000g for 30 min. Next, the
cleared lysate was incubated with 2 mL of Ni-NTA resin for 1
h at 4 °C. After the resin/lysate mixture was transferred to a
column, the resin was washed with high-salt wash buffer (20
mM Tris pH 8.0, 1 M NaCl, 30 mM imidazole, and 10%
glycerol, 2 × 20 mL) followed by a low-salt wash (20 mM Tris
pH 8.0, 150 mM NaCl, and 10% glycerol, 2 × 20 mL). The
proteins were eluted in eight 1 mL portions of 20 mM Tris pH
8.0, 150 mM NaCl, 250 mM imidazole, and 10% glycerol.
Elution fractions were analyzed by SDS-PAGE, combined, and
dialyzed into 20 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT,
and 10% glycerol overnight at 4 °C. ZiF-SNAP-His6 and
ZF5.3-SNAP-His6 were dialyzed into the same buffer
supplemented with 100 μM of ZnCl2. Following dialysis,
each protein was analyzed by mass spectrometry. We observed
that a portion of the expressed ZF5.3-SNAP-His6 contained an
oxidative modification corresponding a mass increase of 80 Da.
Purified ZF5.3-SNAP-His6 was buffer exchanged into Zn-free
SNAP-tag buffer (20 mM Tris pH 8.0, 150 mM NaCl,
containing 10% glycerol). Bond-breaker tris(2-carboxyethyl)
(TCEP) solution was added to 3 mL of 50 μM ZF5.3-SNAP-
His6 to a final concentration of 50 mM. The protein solution
containing the added reducing agent was incubated overnight
at 37 °C. Removal of the 80 Da adduct was confirmed by mass
spectrometry. After removal of the 80 Da adduct, TCEP was
removed from the reaction mixture using a PD-10 column. The
protein was then redialyzed into SNAP-tag buffer supple-
mented with 100 μM ZnCl2 overnight at 4 °C. Protein
concentrations were assessed using the Pierce 660 nm protein
assay and stored at −80 °C until further use.
Expression and Purification of SrtA7M-StrepTagII.
The plasmid encoding SrtA7M-StrepTagII was used to
transform E. coli BL21(DE3) cells. Individual colonies were
selected on the basis of Amp resistance and used to inoculate
50 mL of LB media supplemented with Amp (100 mg/L). The
primary culture was grown overnight and then used to
inoculate 2 L of LB medium supplemented with Amp, which
was then allowed to grow at 37 °C with shaking at 200 rpm.
When the OD600 reached 0.5, the protein expression was
induced by the addition of IPTG to a final concentration of 1
mM. After 4 h, the cells were harvested by centrifugation and
lysed by sonication in 20 mM Tris pH 8.0, 150 mM NaCl, and
10% glycerol, supplemented with one cOmplete, Mini EDTA-
free protease inhibitor cocktail tablet. The cleared lysate was
obtained by centrifugation at 15000g for 30 min. Next, the
cleared lysate was manually added to a 5 mL StrepTrap HP
column. After the lysate was transferred to a column, the
column was washed with 30 mL of 20 mM Tris pH 8.0, 150
mM NaCl, and 10% glycerol. After the column was washed,
SrtA7M-StrepTagII was eluted from the resin using 20 mM
Tris pH 8.0, 150 mM NaCl, and 10% glycerol supplemented
with 2 mM of desthiobiotin in eight 2 mL portions. Elution
fractions were analyzed by SDS-PAGE, combined, and dialyzed
into 20 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT, and 10%
glycerol. Protein concentrations were assessed using the Pierce
660 nm protein assay and stored at −80 °C until further use.
Expression and Purification of APEX2-His6 Con-
structs. Plasmids encoding each His-tagged APEX2 conjugate
were used to transform E. coli BL21(DE3) cells. Individual
colonies were selected on the basis of Amp resistance and used
to inoculate 5 mL of LB media supplemented with Amp (100
mg/L). The primary cultures were used to inoculate 1 L of LB
medium supplemented with Amp, which was then allowed to
grow at 37 °C with shaking at 200 rpm. When the OD600
reached 0.4, the culture was cooled to 25 °C. Protein
expression was induced by the addition of IPTG to a final
concentration of 0.4 mM. At this time, the media were also
supplemented with 1 mM 5-aminolevulinic acid to promote
heme biosynthesis. After 16 h, the cells were harvested by
centrifugation and lysed by sonication in 20 mM Tris pH 8.0,
150 mM NaCl, and 10% glycerol, supplemented with one
cOmplete, mini EDTA-free protease inhibitor cocktail tablet.
The cleared lysate was obtained by centrifugation at 15000g for
30 min. Next, the cleared lysate was incubated with 2 mL of
Ni-NTA resin for 1 h at 4 °C. After the resin/lysate mixture
was transferred to a column, the resin was washed with high-
salt wash buffer (20 mM Tris pH 8.0, 1 M NaCl, 30 mM
imidazole, and 10% glycerol, 2 × 20 mL) followed by a low-salt
wash (20 mM Tris pH 8.0, 150 mM NaCl, and 10% glycerol, 2
× 20 mL). The proteins were eluted in eight 1 mL portions of
20 mM Tris pH 8.0, 150 mM NaCl, 250 mM imidazole, and
10% glycerol. Elution fractions were analyzed by SDS-PAGE,
combined, and dialyzed into 20 mM Tris pH 8.0, 150 mM
NaCl, 1 mM DTT, 10% glycerol, and 100 μM ZnCl2 overnight
at 4 °C. Total protein concentrations were assessed using the
Pierce 660 nm protein assay and stored at −80 °C until further
use.
Synthesis of CPP9/12-PEG2-LPETG3 Peptides. The
synthesis of CPP9-PEG2-LPETG3 and CPP12-PEG2-LPETG3
was based on the method previously reported by Qian et al.76
CPP9-PEG2-LPETG3 and CPP12-PEG2-LPETG3 precursor
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peptides were synthesized on H-Rink Amide-ChemMatrix
resin using a Biotage Alstra automated microwave peptide
synthesizer. Each coupling reaction was performed using 5
equiv of Fmoc-protected amino acid, 5 equiv of 2-(1H-
benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexauorophos-
phate (HBTU), 5 equiv of 1-hydroxybenzotriazole (HOBt),
and 10 equiv of N,N-diisopropylethylamine (DIPEA) in
dimethylformamide (DMF). Fmoc deprotections were per-
formed using 20% piperidine in DMF. Following microwave
synthesis, the resin was transferred to a glass peptide synthesis
vessel, purged with nitrogen, and washed with anhydrous
dichloromethane (DCM). The Glu(OAll) side chain was
deprotected (3 × 20 min) using 0.1 equiv of Pd(PPh3)4 and 10
equiv of phenylsilane in anhydrous DCM. Next, the N-terminal
Fmoc residue was deprotected using 20% piperidine in DMF
(2 × 10 min). Following the deprotection steps, the peptide
was cyclized by stirring the resin with 10 equiv of benzotriazol-
1-yl oxytripyrrolidinophosphonium hexafluorophosphate
(PyBOP) and 20 equiv of DIPEA overnight. The peptides
were deprotected and cleaved from the resin by stirring the
resin in 88% trifluoroacetic acid, 5% triisopropyl silane, 5%
phenol, and 2% water for 2 h at room temperature. Finally, the
peptides were precipitated in cold diethyl ether, isolated by
centrifugation, and purified by reversed-phase HPLC over a
semiprep Grace Vydac C18 (218TP) column. The identity of
each peptide was confirmed by mass spectrometry.
Sortase-Mediated Synthesis of CPP9/CPP12-SNAP-
Tag-His6. MIEGR-G3-SNAP-His6 was overexpressed, purified
by immobilized metal ion chromatography as described above,
and dialyzed into Factor Xa cleavage buffer (20 mM Tris pH
7.0, 150 mM NaCl, 2 mM CaCl2, 10% glycerol) overnight at 4
°C. Quantitative cleavage of the N-terminal MIEGR sequence
was achieved by incubating 10 mg of the purified protein with
50 μg of commercial Factor Xa (NEB) overnight at 30 °C.
Following removal of the N-terminal MIEGR fragment, Factor
Xa was inactivated by the addition of 1 mM TCEP. The
cleaved protein was then dialyzed into 20 mM Tris pH 8.0, 150
mM NaCl, 1 mM DTT, and 10% glycerol for 4 h at 4 °C. To
generate CPP9-SNAP-His6 and CPP12-SNAP-His6, G3-SNAP-
His6 (100 μM) was incubated with SrtA7M-StrepTagII (75
μM) and HPLC purified CPP9-LPETG3 or CPP12-LPETG3
(200 μM) in 2 mL of 20 mM Tris pH 8.0, 150 mM NaCl, 1
mM DTT, and 10% glycerol. Reaction progress was monitored
by LC-MS. After 1 h, good conversion (∼50%) to CPP9-
SNAP-His6 and CPP12-SNAP-His6 was observed. However,
further optimization of the reaction conditions proved difficult.
Increasing the concentration of CPP9-LPETG3 (up to 500
μM) resulted in significant precipitation of the reaction.
Increasing the concentration of SrtA7M-StrepTagII (up to 150
μM) or allowing the reaction to proceed for longer periods of
time (up to 4 h) resulted in reduced formation of the desired
conjugate. We therefore employed a two-step purification
strategy to obtain CPP9-SNAP-His6 and CPP12-SNAP-His6
from a partially labeled mixture with exceptional purity. First,
the reaction mixture was incubated with 500 μL of Ni-NTA
resin for 30 min at 4 °C. The resin was then washed (2 × 10
mL) with high salt buffer (20 mM Tris pH 8.0, 1 M NaCl, 1
mM DTT, and 10% glycerol) to remove CPP9-LPETG3 or
CPP12-LPETG3 and SrtA7M-StrepTagII. An additional wash
was performed with SNAP-tag buffer (20 mM Tris pH 8.0, 150
mM NaCl, 1 mM DTT, and 10% glycerol). The His6 tagged
proteins (G3-SNAP-His6 and CPP9-SNAP-His6 or CPP12-
SNAP-His6) were then eluted from the resin using SNAP-tag
buffer supplemented with 250 mM imidazole. Next, G3-SNAP-
His6 and CPP9-SNAP-His6 or CPP12-SNAP-His6 were
purified over a HiTrapSP HP column using a 60 min NaCl
gradient (0−1.0 M NaCl in 20 mM HEPES, pH 7.0). The
product fractions were pooled, concentrated, and dialyzed into
20 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT, and 10%
glycerol overnight at 4 °C. The identity and purity of isolated
CPP9-SNAP-His6 and CPP12-SNAP-His6 were assessed by
mass spectrometry and SDS-PAGE, respectively.
Synthesis of BG-Rho for SNAP-Tag Labeling. BG-
amine was synthesized in accordance with Keppler et al.67 To
generate BG-Rho, BG-amine (3 mg, 9.8 μmol) was dissolved
in 500 μL of anhydrous dimethyl sulfoxide (DMSO) and
stirred with 3 equiv of lissamine rhodamine B sulfonyl chloride
(11 mg, 29.4) in the presence of excess diisopropylamine (10.2
μL, 58.8 μmol) at room temperature overnight. BG-Rho was
purified from the reaction mixture by reversed-phase HPLC
over a semiprep Grace Vydac C18 (218TP) column and
analyzed by mass spectrometry. HPLC fractions containing
BG-Rho were combined, dried under reduced pressure, and
resuspended in DMSO to yield 2 mM stock solutions for
SNAP-tag labeling experiments.
Preparation of Rho-Tagged SNAP-Tag Proteins. One
milliliter of a 20−40 μM solution of each purified SNAP-tag
conjugate was incubated with 1.5 molar equiv of BG-Rho for 2
h at 37 °C. The labeling reaction was monitored using mass
spectrometry. After the labeling reaction had gone to
completion, excess dye was removed from the protein sample
by exchanging the reaction buffer over a standard PD-10
desalting column. To ensure complete removal of undetectable
remaining BG-Rho, the proteins were dialyzed overnight at 4
°C into 20 mM Tris, 150 mM NaCl, containing 10% glycerol
and 1 mM DTT. Following dialysis, SNAP-Rho proteins were
quantified using an extinction coefficient of lissamine rhod-
amine B (Rho) measured in water (112 000 M−1 cm−1).
Synthesis of NH2-G3K-Rho. The Fmoc-Gly-Gly-Gly-
Lys(Mtt) precursor peptide was synthesized on H-Rink
Amide-ChemMatrix resin using a Biotage Alstra automated
microwave peptide synthesizer as described above. Following
synthesis, the resin was transferred to a glass peptide synthesis
vessel and washed extensively with DCM. Deprotection of Mtt
was achieved by stirring the resin in 2% TFA in DCM (3 × 15
min). Next, the peptide reaction vessel was purged with
nitrogen and the resin was washed with anhydrous DMF and
labeled with lissamine rhodamine B sulfonyl chloride as
described above. After the labeling reaction, the N-terminal
Gly residue was deprotected using 20% piperidine in DMF (2
× 15 min). The resin was then washed, dried, and cleaved in
95% TFA containing 2.5% TIPS and 2.5% H2O for 1 h. The
peptide was then purified by reversed-phase HPLC over a
semiprep Grace Vydac C18 (218TP) column. HPLC fractions
containing the purified peptide were identified by mass
spectrometry, frozen, and dried by lyophilization. The identity
of the purified peptide was confirmed by mass spectrometry.
Sortase-Mediated Synthesis of APEX2-Rho and
ZF5.3-APEX2-Rho. To generate APEX2-Rho and ZF5.3-
APEX2-Rho, APEX2-LPETGG-His6 and ZF5.3-LPETGG-His6
(50 μM) were incubated with SrtA7M-StrepTagII (75 μM)
and HPLC purified NH2-G3K-Rho (300 μM) in 2 mL of 20
mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT, and 10%
glycerol until quantitative labeling was observed by mass
spectrometry. To isolate APEX2-Rho, the sortase labeling
reaction mixture was exchange into low-salt buffer (20 mM
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Tris, pH 8.0), loaded onto a HiTrapQ column, and purified
over a 60 min NaCl gradient (0 to 1.0 M NaCl in 20 mM Tris,
pH 8.0). The fractions containing APEX2-Rho were analyzed
by SDS-PAGE, pooled, and exchanged into 20 mM Tris pH
8.0, 150 mM NaCl, 10% glycerol, 1 mM DTT, and 100 μM
ZnCl2 using a PD-10 desalting column. While we attempted
the same approach to purify ZF5.3-APEX2-Rho, we found that
the labeled protein did not bind to the HiTrapQ column.
Alternatively, we found that ZF5.3-APEX2-Rho (lacking the
His6 tag) retained affinity for TALON resin. We therefore
isolated ZF5.3-APEX2-Rho from the sortase labeling reaction
by directly loading the mixture onto a HiTrap TALON
column. The HiTrap TALON column was washed extensively
(3 × 20 mL) with 20 mM Tris pH 8.0, 150 mM NaCl, and
10% glycerol. ZF5.3-APEX2-Rho was eluted from the resin
over a 60 min imidazole gradient (0−250 mM imidazole in 20
mM Tris, pH 8.0). The fractions containing ZF5.3-APEX2-
Rho were analyzed by SDS-PAGE, pooled, and exchanged into
20 mM Tris pH 8.0, 150 mM NaCl, 10% glycerol, 1 mM DTT,
and 100 μM ZnCl2 using a PD-10 desalting column. The
identity and purity of isolated APEX2-Rho and ZF5.3-APEX2-
Rho were assessed by mass spectrometry and SDS-PAGE,
respectively.
Cell Culture. Saos-2, HeLa, and SK-HEP-1 cell stocks were
purchased from the American Type Culture Collection
(ATCC). Saos-2 cells were cultured in McCoy’s 5A medium
supplemented with 15% fetal bovine serum (FBS), sodium
pyruvate (1 mM), penicillin (100 units/mL), and streptomycin
(100 μg/mL). HeLa cells were cultured in DMEM
supplemented with 10% FBS, penicillin (100 units/mL), and
streptomycin (100 μg/mL). SK-HEP-1 cells were cultured in
EMEM supplemented with 10% FBS, penicillin (100 units/
mL), and streptomycin (100 μg/mL). All cell cultures were
maintained at 37 °C in a humidified atmosphere at 5% CO2.
Confocal Microscopy. Confocal microscopy experiments
were performed on an inverted Zeiss LSM 880 laser scanning
confocal microscope equipped with a Plan-Apochromat 40x/
1.2 NA water immersion lens and a diode pumped solid-state
561 nm laser suitable for excitation of Rho. One day prior to
performing uptake experiments, ∼40 000 Saos-2 cells in 1 mL
of clear McCoy’s 5A medium (no phenol red) containing 15%
FBS were plated in 12-well tissue culture treated plates and
allowed to adhere overnight. The following morning, the cells
were washed three times with DPBS, and the media was
replaced with 500 μL of clear McCoy’s 5A medium containing
1 μM solutions (or 2 μM and 3 μM solutions of ZF5.3-SNAP-
Rho and CPP12-SNAP-Rho as indicated in the titration
experiments) of each Rho-tagged SNAP-tag or APEX2
conjugate. The cells were incubated for 25 min at 37 °C,
after which the cells were treated with 300 nM Hoechst 33342
nuclear stain for 5 additional min. The cells were washed three
times with DPBS prior to lifting with 500 μL of trypsin
(TrypLE Express) for 5 min at 37 °C. The cells were then
transferred to a 15 mL Falcon tube containing 1 mL of clear
McCoy’s medium supplemented with 15% FBS and pelleted at
500g for 2 min. The cells were then washed with 1 mL of
DPBS and pelleted again at 500g for 2 min. Finally, the cells
were suspended in 250 μL of clear DMEM medium and
replated onto fibronectin-coated (diluted 1:100 in DPSB) glass
microscopy dishes. The cells were allowed to adhere to the
microscopy dish for 15 min prior to imaging.
Flow Cytometry. Flow cytometry measurements were
performed using an Attune NxT flow cytometer equipped with
a 561 nm laser for excitation of Rho. One day prior to
performing uptake experiments, ∼40 000 Saos-2 cells in 1 mL
of McCoy’s 5A medium containing 15% FBS were plated into
12-well tissue culture treated plates and allowed to adhere
overnight. The following morning, the cells were washed three
times with DPBS, and the media was replaced with 500 μL of
McCoy’s 5A medium containing 1 μM solutions (or 2 μM and
3 μM solutions of ZF5.3-SNAP-Rho and CPP12-SNAP-Rho as
indicated in the titration experiments) of each Rho-labeled
SNAP-tag or APEX2 conjugate. The cells were incubated for
30 min at 37 °C. The cells were washed three times with DPBS
prior to lifting with 500 μL of trypsin for 5 min at 37 °C. The
cells were then transferred to a 15 mL Falcon tube containing
1 mL of McCoy’s Media supplemented with 15% FBS and
pelleted at 500g for 2 min. The cells were then washed by
resuspension in DPBS and again pelleted at 500 g for 2 min.
The cells were finally suspended in 100 μL of DPBS and
transferred to microcentrifuge tubes prior to obtaining flow
cytometry measurements.
Fluorescence Correlation Spectroscopy. FCS measure-
ments were obtained using an inverted Zeiss LSM 880 laser
scanning confocal microscope equipped with a C-Apochromat
40x/1.2 NA water immersion objective as well as a photon
counting GaAsP detector. One day prior to performing uptake
experiments, ∼40 000 Saos-2 cells in 1 mL of McCoy’s 5A
medium containing 15% FBS were plated into 12-well tissue
culture treated plates and allowed to adhere overnight. The
cells were treated with each Rho-labeled SNAP-tag or APEX2
protein, stained with Hoechst 33342 nuclear stain, and
prepared for FCS in the exact manner as described for the
confocal microscopy measurements. All FCS measurements
were performed at 37 °C in media containing 25 mM HEPES.
Prior to FCS measurements in cells, the focal volume of the
microscope was measured using an Alexa 594 dye standard
solution. To do so, the correction collar of the C-apochromat
40x/N1.2 water immersion objective was adjusted to the
correct cover glass thickness of each 8-well microscopy dish.
The cover glass thickness was measured with a digital
micrometer (Mitutoyo, Aurora, IL). Then, the pinhole of the
561 nm laser was aligned in both the x and the y direction.
FCS traces for a standard solution of Alexa 594 dye (100 nM)
in water were recorded at 37 °C in the same 8-well dish used
for in cellulo FCS experiments (no fibronectin coating for the
Alexa 594 standard). Autocorrelation data were collected over
5-s intervals with 10 repeats. During in cellulo FCS measure-
ments, the cells were scanned visually to identify locations for
cytosolic focal volume placement; nuclear regions, as well as
regions with high punctate signal (endosomes), were avoided.
The FCS traces were fit to a 3D diffusion equation using a
custom MATLAB script as previously described. Briefly,
autocorrelation curves from in vitro measurements were fit to
a 3D diffusion eq (eq 1):
( ) ( )
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( )
1 1
1 1 S
diff
2
diff
τ =
+ +ττ
τ
τ (1)
N is the average number of diffusing molecules in the effective
confocal volume (Veff) and τdiff is the diffusion time, the
average time a molecule takes to transit the laser focus. The
shape factor S of the effective focal volume Veff was determined
from the fit of the autocorrelation function of Alexa 594 (12.5
nM) in water at 25 °C (S = 0.2 ± 0.007) and was fixed for all
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subsequent analyses at S = 0.2. Veff was determined to be 0.66
± 0.090 fL and was calculated according to eqs 2 and 3:
D(4 )1 diffω τ= (2)
V
S
1
eff
3/2
1
3π ω=
(3)
D is the diffusion coefficient of Alexa 594 at 37 °C (5.20 ×
10−6 cm2 s−1), and τdiff is the measured diffusion time (unit of
time). The diffusion coefficient D of Alexa 594 at 37 °C was
calculated using eq 4:
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where t = 37 °C, D of Alexa 594 at is 25 °C (3.88 × 10−6 cm2
s−1),92 and the viscosity η of water at 37 °C is 0.6913 m·Pa·s.
The final concentration C in the effective confocal volume
Veff was calculated as follows (eq 5):
C
N
N VA eff
=
(5)
where NA is Avogardro’s number (6.0221413 × 10
23 mol−1).
Autocorrelation curves from in cellulo measurements were fit
to an anomalous diffusion model:
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(6)
G(∞) represents the level of background autocorrelation at
long time scales and α is the anomalous diffusion coefficient,
which represents the degree to which diffusion is hindered over
long distances.93
The fitted autocorrelation traces from live cell measurements
were then evaluated and filtered as described before.47 We
discarded traces that displayed poor signal with counts per
molecule (cpm) below 1 kHz and/or low anomalous diffusion
coefficients (α < 0.3).94 With these parameters, we typically
retained at least 75% of the collected data points.
Cytosolic Fractionation Assay. One day prior to
performing uptake experiments, ∼5 million Saos-2 cells in 25
mL of McCoy’s 5A medium containing 15% FBS were plated
into T150 tissue culture flasks and allowed to adhere overnight.
The following morning, the cells were washed three times with
DPBS, and the media were replaced with 10 mL of clear
McCoy’s 5A medium containing a 1 μM solution of ZF5.3-
SNAP-Rho or 10 mL of clear McCoy’s 5A medium lacking
added protein. The cells were incubated for 30 min at 37 °C,
washed three times with DPBS, and lifted with 4 mL of trypsin.
The cells were then transferred to 15 mL Falcon tubes
containing 8 mL of clear McCoy’s medium supplemented with
15% FBS and pelleted at 500g for 2 min. The cells were
washed by resuspension with 3 mL of DPBS and pelleted at
500 g for 2 min. This step was repeated to perform a second
wash. After the second DPBS wash, the cells were resuspended
in 1 mL of precooled buffered isotonic sucrose buffer (290
mM sucrose, 10 mM imidazole pH 7.0, 1 mM DTT, and 1
cOmplete protease inhibitor cocktail per 10 mL buffer) and
repelleted at 500g for 2 min. Next, the cells were suspended in
150 μL of isotonic sucrose, transferred to 0.5 mL microtubes
containing 1.4 mm ceramic beads (Omni International) and
homogenized using a Bead Ruptor 4 (Omni International) at
speed 1 for 8 s. The homogenized cells were transferred to
polycarbonate ultracentrifuge tubes and centrifuged at 350 kg
for 30 min at 4 °C to isolate the cytosolic fraction. Next, the
cytosolic fractions were boiled in gel loading buffer and
separated by SDS-PAGE. The gel was analyzed by in-gel
fluorescence scanning (Typhoon FLA 7000) prior to transfer
onto PVDF membranes for Western blot analysis. SNAP-tag
was detected by incubating the membrane with an anti-SNAP-
tag antibody (New England Biolabs, Ipswich, MA) followed by
incubation with an HRP-linked anti-Rabbit IgG antibody (Cell
Signaling Technology, Danvers, MA). The HRP signal was
developed using Clarity Western ECL Substrates (Bio-Rad,
Hercules, CA).
Evaluating SNAP-Tag Activity in cellulo. One day prior
to performing uptake experiments, ∼40 000 Saos-2 cells in 1
mL of McCoy’s 5A medium containing 15% FBS were plated
into 12-well tissue culture treated plates and allowed to adhere
overnight. The following morning, the cells were washed three
times with DPBS, and the media was replaced with 500 μL of
clear McCoy’s 5A medium containing 3 μM solutions of each
unlabeled SNAP-tag protein. The cells were incubated for 30
min at 37 °C, washed three times with DPBS, and then treated
with 500 nM SNAP-Cell© 505-Star in McCoy’s 5A medium
containing 15% FBS. After 40 min, the cells were treated with
300 nM Hoechst 33342 nuclear stain for 5 additional min.
Next, the cells were washed three times with McCoy’s 5A
medium; to washout unreacted dye, the cells were incubated in
fresh medium for an additional 30 min. Finally, the cells were
lifted with trypsin, replated onto fibronectin-coated glass slides,
and evaluated by confocal microscopy and flow cytometry as
described above.
Guaiacol Oxidation Assay. First, the concentration of the
heme-bound form of each enzyme (APEX2, ZF5.3-APEX2,
APEX2-Rho, and ZF5.3-APEX2-Rho) was determined by
absorption at 405 nm using a reported extinction coefficient
corresponding to holo-APEX2.68 APEX2, ZF5.3-APEX2,
APEX2-Rho, and ZF5.3-APEX2-Rho enzymes were added to
buffer (20 mM Tris pH 8.0, 150 mM NaCl, containing 10%
glycerol) containing 1 mM guaiacol and 1 mM hydrogen
peroxide (H2O2) to a final concentration of 500 nM. A sample
lacking added APEX2 enzyme (buffer supplemented with 1
mM guaiacol and 1 mM H2O2) was prepared as a negative
control. All samples were prepared in triplicate. After 5 min,
the absorbance at 470 nm (corresponding to the oxidized
tetraguaiacol product) was recorded using a Tecan Infinite
M1000 plate reader.
Evaluating APEX2 Activity in Cellulo. One day prior to
performing experiments, ∼40 000 Saos-2 cells in 1 mL of
McCoy’s 5A medium containing 15% FBS were plated into 12-
well tissue culture treated plates and allowed to adhere
overnight. The following morning, the cells were washed three
times with DPBS, and the media was replaced with 500 μL of
clear McCoy’s 5A medium containing 500 nM solutions of
heme-bound APEX2 and ZF5.3-APEX2 (1.8 μM and 1.1 μM
total protein, respectively). Next, the cells were washed three
times with DPBS, prior to lifting with 500 μL of trypsin
(TrypLE Express) for 5 min at 37 °C. The cells were then
transferred to a 15 mL Falcon tube containing 1 mL of clear
McCoy’s medium supplemented with 15% FBS and pelleted at
500g for 2 min. The cells were washed again with 1 mL of
DPBS and pelleted at 500g for 2 min. The cells were then
suspended in 100 μL of DPBS containing 10 μM of Amplex
UltraRed and 1 mM H2O2. After 1 min, total intracellular
ACS Central Science Research Article
DOI: 10.1021/acscentsci.8b00446
ACS Cent. Sci. 2018, 4, 1379−1393
1390
fluorescence was analyzed using flow cytometry. For confocal
microscopy experiments, the cells were treated with each
APEX2 enzyme as described above for 25 min followed by a 5
min incubation period with Hoechst 33342 nuclear stain. The
cells were then washed and treated with trypsin as described
above and transferred onto fibronectin-coated microscopy
slides. After 20 min, 10 μM of Amplex UltraRed and 1 mM
H2O2 were added directly to the wells and the cells were
imaged immediately by confocal microscopy.
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